Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1202-1211

  Ryan, Richard R ^a   Katsuno, Tatsuro ^a   Mantey, Samuel A ^a   Pradhan, Tapas K ^a   Weber, H Christian ^a   Coy, David H ^c   Battey, James F ^b   Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE INHIBITOR; NEUROHORMONE; NEUROMEDIN B; PD 168368; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; HORMONE INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CALCIUM; CHO CELLS; CRICETINAE; HUMANS; INDOLES; IODINE RADIOISOTOPES; KINETICS; MICE; PEPTOIDS; RADIOLIGAND ASSAY; RATS; RECEPTORS, BOMBESIN; TUMOR CELLS, CULTURED;

EID: 0032788598     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ali M, Gawin AZ and Baraniuk JN (1996) Effects of bombesin family peptides and antagonists on guinea pig nasal mucosal secretion. J Pharmacol Exp Ther 276: 1266-1271.
2. Beattie DT, Beresford IJM, Connor HE, Marshall FH, Hawcock AB, Hagan RM, Bowers J, Birch PJ and Ward P (1995) The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist. Br J Pharmacol 116:3149-3157.
3. Benya RV, Fathi Z, Pradhan T, Battey JF, Kusui T and Jensen RT (1994) Gastrin-releasing peptide receptor-induced internalization, down-regulation, desensitization and growth: Possible role of cAMP. Mol Pharmacol 46:235-245.
4. Benya RV, Wada E, Battey JF, Fathi Z, Wang LH, Mantey SA, Coy DH and Jensen RT (1992) Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: Analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins and signal transduction and comparison with natively expressed receptors. Mol Pharmacol 42:1058-1068.
5. Corjay MH, Dobrzanski DJ, Way JM, Viallet J, Shapira H, Worland P, Sausville EA and Battey JF (1991) Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J Biol Chem 266:18771-18779.
6. Cridland RA and Henry JL (1992) Bombesin, neuromedin C and neuromedin B given intrathecally facilitate the tail flick reflex in the rat. Brain Res 584:163-168.
7. DeMichele MA, Davis AL, Hunt JD, Landreneau RJ and Siegfried JM (1994) Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells. Am J Respir Cell Mol Biol 11:66-74.
8. Eden JM, Hall MD, Higginbottom M, Horwell DC, Howson W, Hughes J, Jordan RE, Lewthwaite RA, Martin K, McKnight AT, O'Toole JC, Pinnock RD, Pritchard MC, Suman-Chauhan N and Williams SC (1996) PD 165929: The first high affinity non-peptide neuromedin-B (NMB) receptor selective antagonist. Bioorg Med Chem Lett 6:2617-2622.
9. Gibril F, Mrozinski JE, Griffin T, Coy DH, Benya RB, Battey JF and Jensen RT (1994) Identification of selective agonists and antagonists for human bombesin receptors using stably transfected cell lines (Abstract). Gastroenterology 106:A809.
10. Hearn SC, Jones PM, Ghatei MA, Byrne J, Hill SF and Bloom SR (1992) The presence, characterization and synthesis of neuromedin B in the human pituitary gland. Neuroendocrinology 56:729-734.
11. Hou W, Tsuda T and Jensen RT (1998) Neuromedin B activates phospholipase D through both PKC-dependent and PKC-independent mechanisms. Biochem Biophys Acta 1391:337-350.
12. Howard JM, Knight M, Jensen RT and Gardner JD (1984) Discovery of an analogue of cholecystokinin with partial agonist activity. Am J Physiol 247:G261-G264.
13. Jensen RT and Coy DH (1991) Progress in the development of potent bombesin receptor antagonists. Trends Pharmacol Sci 12:13-19.
14. Ladenheim EE and Guss JL (1995) Bombesin receptor subtypes: Implications in bombesin satiety. Appetite 24:261.
15. Ladenheim EE, Taylor JE, Coy DH and Moran TH (1994) Blockade of feeding inhibition by neuromedin B using a selective receptor antagonist. Eur J Pharmacol 271:R7-R9.
16. Lin JT, Coy DH, Mantey SA and Jensen RT (1995) Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes. J Pharmacol Exp Ther 275:285-295.
17. Maggi CA, Patacchini R, Giuliani S and Giachetti A (1993) In vivo and in vitro pharmacology of SR 48,968, a non-peptide NK2 receptor antagonist. Eur J Pharmacol 234:83-90.
18. Mantey SA, Weber HC, Sainz E, Akeson M, Ryan RR, Pradhan TK, Searles RP, Spindel ER, Battey JF, Coy DH and Jensen RT (1997) Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates it has a unique pharmacology compared to other mammalian bombesin receptors. J Biol Chem 272:26062-26071.
19. Mihara S, Hara M, Nakamura M, Sakurawi K, Tokura K, Fujimoto M, Fukai T and Nomura T (1995) Non-peptide bombesin receptor antagonists, kuwanon G and H, isolated from mulberry. Biochem Biophys Res Commun 213:594-599.
20. Minamino N, Kangawa K and Matsuo H (1983) Neuromedin B: A novel bombesin-like peptide identified in porcine spinal cord. Biochem Biophys Res Commun 114:541-548.
21. Moody TW, Korman LY and O'Donohue TL (1986) Neuromedin B-like peptides in rat brain: Biochemical characterization, mechanism of release and localization in synaptosomes. Peptides 7:815-820.
22. Moody TW, Staley J, Zia F, Coy DH and Jensen RT (1992) Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small cell lung cancer cell lines. J Pharmacol Exp Ther 263:311-317.
23. Namba M, Ghatei MA, Bishop AE, Gibson SJ, Mann DJ, Polak JM and Bloom SR (1985) Presence of neuromedin B-like immunoreactivity in the brain and gut of rat and guinea-pig. Peptides 6:257-263.
24. Ohki-Hamazaki H, Wada E, Matsui K and Wada K (1997) Cloning and expression of the neuromedin B receptor and the third subtype of bombesin receptor genes in the mouse. Brain Res 762:165-172.
25. Orbuch M, Taylor JE, Coy DH, Mrozinski JE, Jr., Mantey SA, Battey JF, Moreau JP and Jensen RT (1993) Discovery of a novel class of neuromedin B receptor antagonists: Substituted somatostatin analogues. Mol Pharmacol 44:841-850.
26. Pinnock RD, Reynolds T and Woodruff GN (1994) Different types of bombesin receptors on neurons in the dorsal raphe nucleus and the rostal hypothalamus in rat brain slices in vitro. Brain Res 653:119-124.
27. Pradhan TK, Katsuno T, Ryan RR, Mantey SA, Akeson MA, Spindel ER and Jensen RT (1998) The bombesin receptor subtype 4 is coupled to phospholipase C and has a unique pharmacology (Abstract). Gastroenterology 114:A1173.
28. Rettori V, Milenkovic L, Fahim AM, Polak J, Bloom SR and McCann SM (1989) Role of neuromedin B in the control of the release of thyrotropin in the rat. Proc Natl Acad Sci USA 86:4789-4792.
29. Rouissi N, Rhaleb NE, Nantel F, Dion S, Drapeau G and Regoli D (1991) Characterization of bombesin receptors in peripheral contractile organs. Br J Pharmacol 103:1141-1147.
30. Ryan RR, Taylor JE, Daniel JL and Cowan A (1996) Pharmacological profiles of two bombesin analogues in cells transfected with human neuromedin B receptors. Eur J Pharmacol 306:307-314.
31. Ryan RR, Weber HC, Hou W, Sainz E, Mantey SA, Battey JF, Coy DH and Jensen RT (1998a) Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3. J Biol Chem 273:13613-13624.
32. Ryan RR, Weber HC, Mantey SA, Hou W, Hilburger ME, Pradhan TK, Coy DH and Jensen RT (1998b) Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells. J Pharmacol Exp Ther 287:366-380.
33. Schmassmann A, Garner A, Flogerzi B, Hasan MY, Sanner M, Varga L and Halter F (1994) Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat. Gut 35:270-274.
34. rho and integrity of the acini cytoskeleton. Biochemistry 36:16328-16337.
35. Varga G, Liehr RM, Scarpignato C and Coy DH (1995) Distinct receptors mediate gastrin-releasing peptide and neuromedin B-induced delay of gastric emptying of liquids in rats. Eur J Pharmacol 286:109-112.
36. Vigne P, Feolde E, Van Renterghem C, Breittmayer JP and Frelin C (1997) Properties and functions of a neuromedin-B-preferring bombesin receptor in brain microvascular endothelial cells. Eur J Biochem 272:R433-R437.
37. von Schrenck T, Heinz-Erian P, Moran T, Mantey SA, Gardner JD and Jensen RT (1989) Neuromedin B receptor in esophagus: Evidence for subtypes of bombesin receptors. Am J Physiol 256:G747-G758.
38. Wada E, Way J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D, Jensen R and Battey J (1991) cDNA cloning, characterization, and brain region-specific expression of a neuromedin B-preferring bombesin receptor. Neuron 6:421-430.
39. 2+ and phosphoinositides. Biochem J 286:641-648.
40. Wang LH, Coy DH, Taylor JE, Jiang NY, Moreau JP, Huang SC, Frucht H, Haffar BM and Jensen RT (1990) Des-Met carboxyl-terminally modified analogues of bombesin function as potent bombesin receptor antagonists, partial agonists, or agonists. J Biol Chem 265:15695-15703.